A Canadian-led, international, interdisciplinary research project focused on the development of novel gene therapies to combat incurable neurological disorders. This innovative research project is supported by a $24 million New Frontiers in Research Fund-Transformation Program Grant.
Optimize neuronal reprogramming gene cargo to engineer clinically relevant neuronal types.
Develop astrocyte-specific delivery system(s).
Assess outcome measures in animal models.
Lived experience panel and law, governance and bioethics cross-cutting platform.